<?xml version='1.0' encoding='utf-8'?>
<document id="27207573"><sentence text="Subtherapeutic voriconazole concentrations associated with concomitant dexamethasone: case report and review of the literature."><entity charOffset="15-27" id="DDI-PubMed.27207573.s1.e0" text="voriconazole" /><entity charOffset="71-84" id="DDI-PubMed.27207573.s1.e1" text="dexamethasone" /><pair ddi="false" e1="DDI-PubMed.27207573.s1.e0" e2="DDI-PubMed.27207573.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27207573.s1.e0" e2="DDI-PubMed.27207573.s1.e1" /></sentence><sentence text="Voriconazole has significant drug interactions due to metabolism by CYP enzymes"><entity charOffset="0-12" id="DDI-PubMed.27207573.s2.e0" text="Voriconazole" /></sentence><sentence text=" Subtherapeutic voriconazole concentrations associated with concomitant dexamethasone are not well described"><entity charOffset="16-28" id="DDI-PubMed.27207573.s3.e0" text="voriconazole" /><entity charOffset="72-85" id="DDI-PubMed.27207573.s3.e1" text="dexamethasone" /><pair ddi="false" e1="DDI-PubMed.27207573.s3.e0" e2="DDI-PubMed.27207573.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27207573.s3.e0" e2="DDI-PubMed.27207573.s3.e1" /></sentence><sentence text="" /><sentence text="An 84-year-old male was started on voriconazole for a fungal brain abscess"><entity charOffset="35-47" id="DDI-PubMed.27207573.s5.e0" text="voriconazole" /></sentence><sentence text=" He was readmitted due to clinical failure thought to be the result of subtherapeutic voriconazole concentrations"><entity charOffset="86-98" id="DDI-PubMed.27207573.s6.e0" text="voriconazole" /></sentence><sentence text=" Dexamethasone was identified as a potential cause due to its induction of CYP enzymes"><entity charOffset="1-14" id="DDI-PubMed.27207573.s7.e0" text="Dexamethasone" /></sentence><sentence text=" This interaction was substantiated by sequential troughs that demonstrated a rise in voriconazole concentrations as dexamethasone was tapered off"><entity charOffset="86-98" id="DDI-PubMed.27207573.s8.e0" text="voriconazole" /><entity charOffset="117-130" id="DDI-PubMed.27207573.s8.e1" text="dexamethasone" /><pair ddi="false" e1="DDI-PubMed.27207573.s8.e0" e2="DDI-PubMed.27207573.s8.e0" /><pair ddi="false" e1="DDI-PubMed.27207573.s8.e0" e2="DDI-PubMed.27207573.s8.e1" /></sentence><sentence text="" /><sentence text="Therapeutic drug monitoring for patients on voriconazole and dexamethasone is essential to prevent suboptimal clinical outcomes"><entity charOffset="44-56" id="DDI-PubMed.27207573.s10.e0" text="voriconazole" /><entity charOffset="61-74" id="DDI-PubMed.27207573.s10.e1" text="dexamethasone" /><pair ddi="false" e1="DDI-PubMed.27207573.s10.e0" e2="DDI-PubMed.27207573.s10.e0" /><pair ddi="false" e1="DDI-PubMed.27207573.s10.e0" e2="DDI-PubMed.27207573.s10.e1" /></sentence><sentence text="" /></document>